Shanghai Sanyou Medical Co Ltd (688085) - Total Liabilities
Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) has total liabilities worth CN¥247.79 Million CNY (≈ $36.26 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Sanyou Medical Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688085 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Shanghai Sanyou Medical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai Sanyou Medical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nilfisk Holding A/S
CO:NLFSK
|
Denmark | Dkr588.00 Million |
|
FBD Holdings PLC
IR:EG7
|
Ireland | €927.86 Million |
|
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd
SHE:300384
|
China | CN¥541.65 Million |
|
Beijing Jiaxun Feihong Electrical Co Ltd
SHE:300213
|
China | CN¥876.89 Million |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
USA | $3.49 Billion |
|
Sella Real Estate
TA:SLARL
|
Israel | ILA3.40 Billion |
|
Grupo Supervielle S.A
F:189A
|
Germany | €5.10 Trillion |
|
DukSan Neolux Co.Ltd
KQ:213420
|
Korea | ₩236.09 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Shanghai Sanyou Medical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shanghai Sanyou Medical Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Sanyou Medical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Sanyou Medical Co Ltd (2016–2024)
The table below shows the annual total liabilities of Shanghai Sanyou Medical Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥257.91 Million ≈ $37.74 Million |
+17.88% |
| 2023-12-31 | CN¥218.80 Million ≈ $32.02 Million |
-21.40% |
| 2022-12-31 | CN¥278.35 Million ≈ $40.73 Million |
+6.69% |
| 2021-12-31 | CN¥260.90 Million ≈ $38.18 Million |
+91.49% |
| 2020-12-31 | CN¥136.25 Million ≈ $19.94 Million |
+19.87% |
| 2019-12-31 | CN¥113.67 Million ≈ $16.63 Million |
+135.16% |
| 2018-12-31 | CN¥48.34 Million ≈ $7.07 Million |
+3.34% |
| 2017-12-31 | CN¥46.78 Million ≈ $6.84 Million |
+138.84% |
| 2016-12-31 | CN¥19.58 Million ≈ $2.87 Million |
-- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more